Evidence map›Paper›PMID 38328267›Full record

ArticleCancer care research online2023

Clinic-based Assessment and Support for Family Caregivers of Patients With Cancer: Results of a Feasibility Study.

Madhuvanthi Suresh, Rashmi Risbud, Manali I Patel, Karl A Lorenz, Lidia Schapira, Dolores Gallagher-Thompson, Ranak Trivedi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer care research online, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Madhuvanthi SureshDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).
Rashmi RisbudDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).
Manali I PatelDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).
Karl A LorenzDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).
Lidia SchapiraDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).
Dolores Gallagher-ThompsonDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).
Ranak TrivediDepartment of Neurological Sciences, Rush University Medical Center, Chicago, USA (Dr Suresh); Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, CA, USA (Drs Suresh, Lorenz and Trivedi, Ms Risbud); Division of Oncology, Stanford University School of Medicine, Stanford, CA USA (Dr Patel); Medical Services, VA Palo Alto Health Care System, Palo Alto, CA USA (Drs Patel and Lorenz); Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA (Dr Shapira); Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA (Dr Gallagher-Thompson); Division of Public Mental Health and Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA, USA (Dr Trivedi).

Funding

Telemonitoring Enhanced Support for Depression Self ManagementR01MH096699 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AIKENS, JAMES E · 2012 to 2016
$3.1M
NIMH NIH HHS R01 MH096699
6 · The paper itself

Abstract

Background: Cancer caregiving is burdensome with unique needs, highlighting the importance of assessing caregivers' distress. Caregivers often accompany patients to healthcare visits, presenting an opportunity to complete distress screening at patients' point-of-care. Objective: To evaluate the feasibility of caregiver distress screening at patients' point-of-care and implementing a caregiver psychoeducational session. Methods: We approached caregivers in outpatient cancer clinic waiting rooms. Participants completed depression, burden, anxiety, quality of life, and stress measures. A psychoeducational session with a psychologist was offered to those meeting clinical cutoffs for depression and/or burden. Fifty caregivers completed 1+ measure; however, due to incomplete consent documentation, findings from 23 caregivers are reported. Results: 22% of caregivers screened positive for depression, 30% burden, and 70% anxiety. More than half rated stress as moderate or higher. Mental wellbeing was slightly below that of the general population. More than 75% screened positive on 1+ distress measure. Of the 9 caregivers who met cutoffs for depression and/or burden, two (22%) accepted the psychoeducational session. Conclusion: Caregivers were moderately receptive to distress screening during patients' visits, but were less receptive to engaging in the psychoeducational session due to time constraints and privacy concerns. Implications for Practice: Assessing caregivers' distress can facilitate referrals for supportive services. Offering caregivers psychoeducational intervention outside of patient care may not be acceptable. Future research may evaluate the integration of routine caregiver screening within patient care to promote engagement with mental health services. Foundational: This research offers a unique method of assessing cancer caregivers' distress.

Identifiers

PMID38328267
PMCPMC10846853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.